Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
International Journal of Nanomedicine|January 31, 2012
Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micellesFeihu Wang, Yuxuan Chen, Dianrui Zhang, et al.International Journal of Pharmaceutics|June 27, 2012
Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridoninDandan Zheng, Cunxian Duan, Dianrui Zhang, et al.International Journal of Pharmaceutics|October 20, 2012
Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugsLejiao Jia, Jingyi Shen, Zhenyu Li, et al.Journal of Microencapsulation|May 7, 2011
Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendateFeifei Feng, Dandan Zheng, Dianrui Zhang, et al.Biomacromolecules|November 15, 2011
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridoninCunxian Duan, Jian Gao, Dianrui Zhang, et al.Nanotechnology|March 25, 2010
In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous deliveryYancai Wang, Dianrui Zhang, Zhaoping Liu, et al.Colloids and Surfaces. B, Biointerfaces|December 24, 2010
Development and in vitro evaluation of deacety mycoepoxydiene nanosuspensionYancai Wang, Zhaoping Liu, Dianrui Zhang, et al.International Journal of Pharmaceutics|August 27, 2013
Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugatesJingyi Shen, Dianrui Zhang, Zhongxi Zhao, et al.Cancer Letters|April 22, 2011
In vitro antitumor activity of silybin nanosuspension in PC-3 cellsDandan Zheng, Yancai Wang, Dianrui Zhang, et al.Journal of Biomedical Nanotechnology|December 27, 2011
Development and in vitro characterizations of bifendate nanosuspensionsYue Liu, Dianrui Zhang, Dongna Zou, et al.Pageof 5